nobiletin has been researched along with thromboplastin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, T; Hirata, Y; Ishii, H; Ito, A; Kakutani, H; Masuda, Y; Nakagawa, Y; Takada, K | 1 |
| Barra, G; Borgia, F; Cimmino, G; Cirillo, P; Conte, S; De Palma, R; Pellegrino, G; Sasso, FC; Trimarco, B; Ziviello, F | 1 |
2 other study(ies) available for nobiletin and thromboplastin
| Article | Year |
|---|---|
Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Topics: Animals; Cells, Cultured; Citrus; Flavones; Gene Expression Regulation; Humans; Lipopolysaccharides; Monocytes; NF-kappa B; Plant Extracts; Rabbits; Sp1 Transcription Factor; Thromboplastin; Transcription Factor AP-1 | 2008 |
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB.
Topics: Cardiovascular Agents; Flavones; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins, LDL; NF-kappa B; Oxidative Stress; RNA, Messenger; Thromboplastin | 2017 |